1. Home
  2. THTX

THTX

Theratechnologies Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Founded: 1993 Country:
Canada
Canada
Employees: N/A City: N/A
Market Cap: 62.5M IPO Year: N/A
Target Price: $18.67 AVG Volume (30 days): 50.8K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.41 EPS Growth: N/A
52 Week Low/High: $0.88 - $4.32 Next Earning Date: 04-10-2024
Revenue: $57,854,074 Revenue Growth: -4.06%
Revenue Growth (this year): 11.13% Revenue Growth (next year): 8.17%

Share on Social Networks: